Histogenics
VerifiedTissue regeneration company developing breakthrough treatments for long-lasting joint repair.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$196—294m (Dealroom.co estimates Jul 2012.)
Waltham Massachusetts (HQ)
Deals in current and previous year:
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor | $0.0 | round |
| N/A | $0.0 | round | |
| investor investor investor | $0.0 | round | |
| investor investor | $0.0 | round | |
| N/A | $0.0 | round | |
| investor investor | $0.0 | round | |
* | N/A | $17.0m | Post IPO Equity |
| Total Funding | 000k | ||
Related Content
Recent News about Histogenics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Histogenics
Edit
ACQUISITION by Histogenics May 2011